Stretch Marks Treatment Market Size, Share & Trends Analysis Report By Treatment (Topical Products, Laser, Microdermabrasion, Oils & Serums), By Region, And Segment Forecasts, 2024 - 2030

Stretch Marks Treatment Market Size, Share & Trends Analysis Report By Treatment (Topical Products, Laser, Microdermabrasion, Oils & Serums), By Region, And Segment Forecasts, 2024 - 2030


Stretch Marks Treatment Market Growth & Trends

The global stretch marks treatment market size is expected to reach USD 529.13 million by 2030, registering a CAGR of 9.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing awareness among women regarding the treating stretch marks caused during pregnancy is significantly driving the growth. Also, the growing prevalence of stretch marks in adolescents and teenagers is predicted to fuel the demand for their treatment.

High number of obese population in North America is majorly driving the market in the region. This is an opportunity for the players for expanding their consumer target and strengthening their market presence. Moreover, the increasing number of key players in the region is another factor driving the competition, thereby positively influencing the stretch marks treatment market.

Growing number of online portals for the sale of topical products for treating stretch marks is another opportunity for the players. The key players can thus, increase their sale through these online portals and expand their product portfolio. Moreover, consumer preference for topical products is augmenting its demand, thus affecting the market.

Rise in the launch of new products and adoption of growth strategies, such as partnerships and innovations are trending in the market. Growing Asia Pacific economies and rise in spending power of consumers in these regions is also influencing the market growth positively.

Stretch Marks Treatment Market Report Highlights
  • Topical products is the leading segment owing to increasing cases of stretch marks caused due to pregnancy, obesity, history of delivering twins or large babies, pale skin, sudden weight loss or gain, and others
  • Creams segment is expected to grow considerably during the forecast period owing to increased sales due to high demand, rise in disposable income of consumers, and increased promotion of creams
  • Fractional laser segment is expected to grow substantially over the forecast period, since these products improve the skin tone, reduce the common signs of aging, and enhance the skin texture
  • Pulse-dye lasers domain is also growing significantly due to completely safety assurance for the patients, no need of anesthesia since the machine produces cold spray just before pulsing, eliminating the pain sensation
  • Asia Pacific is the dominant segment in the stretch marks treatment market owing to increasing disposable income, changing lifestyle, and emerging online shopping portals
Please note The report will be delivered in 4-8 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Treatment
1.2.2. Estimates and forecast timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity price analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Treatment Segment
2.2.2. Regional Outlook
2.3. Competitive Insights
Chapter 3. Global Stretch Marks Treatment Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing incidence of obesity globally
3.2.1.2. Rising number of pregnancies and concerns about stretch marks
3.2.1.3. Advancements in treatment technologies
3.2.2. Market restraint analysis
3.2.2.1. High cost of the advanced treatment
3.2.2.2. Risk of side effects and complications
3.3. Stretch Marks Treatment Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Stretch Marks Treatment Market: Treatment Estimates & Trend Analysis
4.1. Stretch Marks Treatment Market: Treatment Dashboard
4.2. Stretch Marks Treatment Market: Treatment Movement Analysis
4.3. Stretch Marks Treatment Market Size & Forecasts and Trend Analysis, by Treatment, 2018 to 2030 (USD Million)
4.4. Topical Products
4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.4.2. Creams
4.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.4.3. Oils & Serums
4.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.4.4. Lotions
4.4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. Laser
4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Fractional Laser
4.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. Pulse-Dye Laser
4.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.4. Others
4.5.4.1 Market estimates and forecast 2018 to 2030 (USD Million)
4.6. Microdermabrasion
4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Stretch Marks Treatment Market: Regional Estimates & Trend Analysis by Country, Treatment.
5.1. Global Stretch Marks Treatment Market: Regional Dashboard
5.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
5.3. North America
5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.2. U.S.
5.3.2.1. Key country dynamics
5.3.2.2. Regulatory framework/ reimbursement structure
5.3.2.3. Competitive scenario
5.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
5.3.3. Canada
5.3.3.1. Key country dynamics
5.3.3.2. Regulatory framework/ reimbursement structure
5.3.3.3. Competitive scenario
5.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
5.3.4. Mexico
5.3.4.1. Key country dynamics
5.3.4.2. Regulatory framework/ reimbursement structure
5.3.4.3. Competitive scenario
5.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
5.4. Europe
5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.2. UK
5.4.2.1. Key country dynamics
5.4.2.2. Regulatory framework/ reimbursement structure
5.4.2.3. Competitive scenario
5.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
5.4.3. Germany
5.4.3.1. Key country dynamics
5.4.3.2. Regulatory framework/ reimbursement structure
5.4.3.3. Competitive scenario
5.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
5.4.4. France
5.4.4.1. Key country dynamics
5.4.4.2. Regulatory framework/ reimbursement structure
5.4.4.3. Competitive scenario
5.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
5.4.5. Italy
5.4.5.1. Key country dynamics
5.4.5.2. Regulatory framework/ reimbursement structure
5.4.5.3. Competitive scenario
5.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
5.4.6. Spain
5.4.6.1. Key country dynamics
5.4.6.2. Regulatory framework/ reimbursement structure
5.4.6.3. Competitive scenario
5.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
5.4.7. Sweden
5.4.7.1. Key country dynamics
5.4.7.2. Regulatory framework/ reimbursement structure
5.4.7.3. Competitive scenario
5.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
5.4.8. Norway
5.4.8.1. Key country dynamics
5.4.8.2. Regulatory framework/ reimbursement structure
5.4.8.3. Competitive scenario
5.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
5.4.9. Denmark
5.4.9.1. Key country dynamics
5.4.9.2. Regulatory framework/ reimbursement structure
5.4.9.3. Competitive scenario
5.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
5.5. Asia Pacific
5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.5.2. China
5.5.2.1. Key country dynamics
5.5.2.2. Regulatory framework/ reimbursement structure
5.5.2.3. Competitive scenario
5.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
5.5.3. Japan
5.5.3.1. Key country dynamics
5.5.3.2. Regulatory framework/ reimbursement structure
5.5.3.3. Competitive scenario
5.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
5.5.4. India
5.5.4.1. Key country dynamics
5.5.4.2. Regulatory framework/ reimbursement structure
5.5.4.3. Competitive scenario
5.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
5.5.5. Australia
5.5.5.1. Key country dynamics
5.5.5.2. Regulatory framework/ reimbursement structure
5.5.5.3. Competitive scenario
5.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
5.5.6. Thailand
5.5.6.1. Key country dynamics
5.5.6.2. Regulatory framework/ reimbursement structure
5.5.6.3. Competitive scenario
5.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
5.5.7. South Korea
5.5.7.1. Key country dynamics
5.5.7.2. Regulatory framework/ reimbursement structure
5.5.7.3. Competitive scenario
5.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
5.6. Latin America
5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.6.2. Brazil
5.6.2.1. Key country dynamics
5.6.2.2. Regulatory framework/ reimbursement structure
5.6.2.3. Competitive scenario
5.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
5.6.3. Argentina
5.6.3.1. Key country dynamics
5.6.3.2. Regulatory framework/ reimbursement structure
5.6.3.3. Competitive scenario
5.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
5.7. MEA
5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.7.2. Saudi Arabia
5.7.2.1. Key country dynamics
5.7.2.2. Regulatory framework/ reimbursement structure
5.7.2.3. Competitive scenario
5.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
5.7.3. South Africa
5.7.3.1. Key country dynamics
5.7.3.2. Regulatory framework/ reimbursement structure
5.7.3.3. Competitive scenario
5.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
5.7.4. UAE
5.7.4.1. Key country dynamics
5.7.4.2. Regulatory framework/ reimbursement structure
5.7.4.3. Competitive scenario
5.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
5.7.5. Kuwait
5.7.5.1. Key country dynamics
5.7.5.2. Regulatory framework/ reimbursement structure
5.7.5.3. Competitive scenario
5.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Manufacturers
6.2. Company/Competition Categorization
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company market share analysis, 2023
6.3.4. Alliance Pharma PLC
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Product benchmarking
6.3.4.4. Strategic initiatives
6.3.5. Basq Skincare
6.3.5.1. Company overview
6.3.5.2. Financial performance
6.3.5.3. Product benchmarking
6.3.5.4. Strategic initiatives
6.3.6. Clarins Group
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Product benchmarking
6.3.6.4. Strategic initiatives
6.3.7. Candela Corporation
6.3.7.1. Company overview
6.3.7.2. Financial performance
6.3.7.3. Product benchmarking
6.3.7.4. Strategic initiatives
6.3.8. Dermaclara Inc.
6.3.8.1. Company overview
6.3.8.2. Financial performance
6.3.8.3. Product benchmarking
6.3.8.4. Strategic initiatives
6.3.9. E.T. Browne Drug Co. Inc. (Palmers)
6.3.9.1. Company overview
6.3.9.2. Financial performance
6.3.9.3. Product benchmarking
6.3.9.4. Strategic initiatives
6.3.10. Helix BioMedix Inc.
6.3.10.1. Company overview
6.3.10.2. Financial performance
6.3.10.3. Product benchmarking
6.3.10.4. Strategic initiatives
6.3.11. HRA Pharma
6.3.11.1. Company overview
6.3.11.2. Financial performance
6.3.11.3. Product benchmarking
6.3.11.4. Strategic initiatives
6.3.12. Laboratoires Expanscience
6.3.12.1. Company overview
6.3.12.2. Financial performance
6.3.12.3. Product benchmarking
6.3.12.4. Strategic initiatives
6.3.13. Union Swiss (Pty) Ltd
6.3.13.1. Company overview
6.3.13.2. Financial performance
6.3.13.3. Product benchmarking
6.3.13.4. Strategic initiatives
6.3.14. Weleda AG Source
6.3.14.1. Company overview
6.3.14.2. Financial performance
6.3.14.3. Product benchmarking
6.3.14.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings